$1.80
-0.08-4.26%
At Close: -
$1.81
0.010.56%
After Hours: 7:11 PM EDT
15 minutes delayed
LAVA Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of LAVA Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LVTX | LAVA Therapeutics | -$0.48 | — | — | — | $5.14M | — | — | — | 08/20/2024 | Get Alert |
LVTX | LAVA Therapeutics | -$0.53 | -$0.12 | -$0.02 | 83.33% | $1.22M | $7.00M | $6.99M | -0.11% | 05/21/2024 | Get Alert |
LVTX | LAVA Therapeutics | -$0.57 | -$0.12 | -$0.24 | -100.00% | $2.64M | $6.25M | $353.00K | -94.35% | 03/20/2024 | Get Alert |
LVTX | LAVA Therapeutics | $0.04 | — | -$0.34 | — | $15.26M | — | $53.00K | — | 11/16/2023 | Get Alert |
LVTX | LAVA Therapeutics | -$0.31 | -$0.47 | -$0.48 | — | $468.00K | $830.00K | $5.14M | 519.16% | 08/22/2023 | Get Alert |
LVTX | LAVA Therapeutics | -$0.41 | -$0.52 | -$0.53 | -1.92% | $1.00M | — | $1.22M | — | 06/08/2023 | Get Alert |
LVTX | LAVA Therapeutics | -$0.32 | -$0.64 | -$0.57 | 10.94% | $1.00M | $250.00K | $2.64M | 956.00% | 04/11/2023 | Get Alert |
LVTX | LAVA Therapeutics | -$0.27 | -$0.15 | $0.04 | 126.67% | $2.10M | $10.53M | $15.26M | 44.93% | 11/16/2022 | Get Alert |
LVTX | LAVA Therapeutics | -$0.31 | -$0.60 | -$0.31 | 48.33% | $1.08M | $340.00K | $468.00K | 37.65% | 09/13/2022 | Get Alert |
LVTX | LAVA Therapeutics | -$12.29 | -$0.86 | -$0.41 | 52.33% | $1.11M | — | $1.00M | — | 05/17/2022 | Get Alert |
LVTX | LAVA Therapeutics | -$12.97 | -$0.40 | -$0.32 | 20.00% | $2.00M | — | $1.00M | — | 03/24/2022 | Get Alert |
LVTX | LAVA Therapeutics | -$8.43 | -$0.31 | -$0.27 | 12.90% | $827.00K | — | $2.10M | — | 11/15/2021 | Get Alert |
LVTX | LAVA Therapeutics | — | -$0.27 | -$0.28 | -3.70% | — | — | $1.08M | — | 08/16/2021 | Get Alert |
LVTX | LAVA Therapeutics | — | — | -$12.29 | — | — | — | $1.11M | — | 05/20/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-21 | $-0.02 | $-0.12 | 83.3 % |
Dec 2023 | 2024-03-20 | $-0.24 | $-0.12 | -100.0 % |
Mar 2023 | 2023-06-08 | $-0.53 | $-0.52 | -1.92 % |
Mar 2023 | 2023-04-11 | $-0.57 | $-0.64 | 10.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-21 | $6.99M | $7.00M | -0.11 % |
Dec 2023 | 2024-03-20 | $353.00K | $6.25M | -94.3 % |
Jun 2023 | 2023-08-22 | $5.14M | $830.00K | 519.2 % |
Mar 2023 | 2023-04-11 | $2.64M | $250.00K | 956.0 % |
LAVA Therapeutics (LVTX) is scheduled to report earnings on August 20, 2024. The last reported earnings were for reported on May 21, 2024 for Q1.
The Actual EPS was $-0.02, which beat the estimate of $-0.12.
The Actual Revenue was $7M, which missed the estimate of $7M.
Browse earnings estimates, EPS, and revenue on all stocks.